In 2010, Kaneda and colleagues reported that FOXQ1 expression is strongly increased in tissue samples from patients with colorectal cancer (CRC), and that its induction inhibited the apoptosis of CRC cell lines in the presence of chemotherapeutic drugs [22]. Here, FOXQ1 is linked to colorectal carcinoma.